• Fetck KC Callout
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspective
Weekly Newscast
dvm360 Insights™
dvm360 LIVE!™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Client Handouts
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2022 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

USDA grants license approval for Circumvent CML vaccine for pigs

June 8, 2022
dvm360 Staff

Merck claims the vaccine is effective against disease caused by Porcine Circovirus Types 2a and 2d, Mycoplasma hyopneumoniae and Lawsonia intracellularis in pigs, 3 weeks of age and older

Merck Animal Health announced today that it has received license approval in the US from the Department of Agriculture (USDA) for its Circumvent CML vaccine. Merck issued a press release that claims Circumvent CML is the first-ready-to-use, single-dose vaccine effective against disease caused by Porcine Circovirus Types 2a and 2d, Mycoplasma hyopneumoniae, and Lawsonia intracellularis in pigs, 3 weeks of age or older.1

The Circumvent CML product label provided by Merck additionally claims that the duration of immunity for Porcine Circovirus Type 2d is at least 16 weeks, the duration for immunity for Mycoplasma hyopneumoniae is at least 10 weeks, and the Duration of immunity for ileitis due to Lawsonia intracellularis is at least 20 weeks. However, the duration of immunity for Porcine Circovirus Type 2a has not been established.2

“Merck Animal Health is excited to bring this important innovation to our customers as part of our commitment to offering comprehensive solutions for improved animal health outcomes,” said Jamie Lehman, DVM, swine technical services veterinarian at Merck Animal Health.

“This vaccine nicely complements Circumvent PCV G2, PCV-M G2, and Porcilis Ileitis product portfolio, providing swine veterinarians and producers the additional option of vaccinating against disease caused by PCV2, Mycoplasma hyopneumoniae, and Lawsonia intracellularis all in 1 bottle.”

Merck says Circumvent CML will be available in 50-ml, 250-ml, and eventually, 500-ml dose presentations, beginning in early 2023.

References

  1. Merck Animal Health Receives License Approval for CIRCUMVENT® CML Vaccine. News release. June 8, 2022. Accessed June 8, 2022. https://www.merck-animal-health-usa.com/uncategorized/merck-animal-health-receives-license-approval-for-circumvent-cml-vaccine
  2. Circumvent® C-M-L (MERCK ANIMAL HEALTH). DVM Metrics and Services, LLC. Accessed June 8, 2022. https://merckusa.cvpservice.com/product/basic/view/1047582?key=label

Related Content:

MedicalFood Animals
A deep dive into rabbit gastrointestinal stasis syndrome
A deep dive into rabbit gastrointestinal stasis syndrome
Grounding objects, wellness, and energy management
Grounding objects, wellness, and energy management
The value of servant leadership, culture, and community connection
The value of servant leadership, culture, and community connection

Latest News

Mini donkey successfully receives pacemaker to manage fatal heart condition

News wrap-up: This week’s headlines, plus Cincinnati Zoo welcomes baby hippo

Dr Mike Nolan receives 2022 AVMF/EveryCat Health Foundation Research Award

Lear's macaw reintroduced into wild and flourishing

View More Latest News